Current aspects in the immunopharmacology of asthma.
D000287:Administration, Topical; D000485:Allergens; D000707:Anaphylaxis / Q000188:drug therapy; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000906:Antibodies; D000937:Antigen-Antibody Reactions; D001249:Asthma / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D001481:Basal Metabolism; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002118:Calcium / Q000502:physiology; D002395:Catecholamines / Q000627:therapeutic use*; D003888:Desensitization, Immunologic; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006969:Hypersensitivity, Immediate
D000485:Allergens; D000893:Anti-Inflammatory Agents; D000906:Antibodies; D001993:Bronchodilator Agents; D002395:Catecholamines; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D002118:Calcium